SOM230, a New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary Adenomas
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2505
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)